Resistance to therapy may result from various factors, and mutations in genes encoding SSRT may be significant, leading to structural changes in receptors.
← all excerpts
The Role of Receptor-Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors.
1
—
—